UBI, listed on the Australian Securities Exchange, operates from its headquarters in Melbourne, Australia. They have successfully launched products such as a handheld wine analyzer and a blood coagulation analyzer in the EU and UK. UBI is also set to launch a veterinary blood glucometer for monitoring diabetes in pets. These products complement their existing Canadian blood testing laboratory.